None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Left atrium size of atrial fibrillation patients < 55 mm 2. Atrial fibrillation with antiarrhythmic resistance 3. Patients with anticoagulant therapy (admission of anti-coagulation drugs to prevent cerebral infarction)
Exclusion criteria
Exclusion criteria: 1. Atrial fibrillation accompanied by structural heart disease affected by severe cardiac deformity or hemodynamic effects 2. Patients receiving treatment for cognitive dysfunction, emotional disorder, and anxiety disorder 3. Patients with active internal bleeding 4. Anticoagulant maladjustment 5. Significant comorbidities of symptoms 6. Patients expected to have a survival period of less than one year. 7. Patients with drug or alcoholism 8. Among the subjects, those who cannot read the consent form (literacy, foreigners, etc.) 9. Patients who are deemed unfit to participate in clinical research based on the judgment of other researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| rate of hospitalization;Major cardiovascular seizure rates;mortality;recurrence rate of atrial fibrillation | — |
Secondary
| Measure | Time frame |
|---|---|
| Major complication associated with the procedure : complication of hemorrhagic and embolic | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital